Clinical trial • Phase I • Infectious Disease
Clinical trial in Human immunodeficiency virus (HIV) infection
Phase I trial for Human immunodeficiency virus (HIV) infection. 6 participants.
Overview
- Trial Therapeutic Area
- Infectious Disease
- Trial Disease
- Human immunodeficiency virus (HIV) infection
- Trial Stage
- Phase I
Key dates
- Initial CTIS Submission Date
- 11-10-2023
- First CTIS Authorization Date
- 09-02-2024
Trial design
Phase I trial across 1 site in Netherlands.
- Target Sample Size
- 6
- Trial Duration For Participant
- 483
Eligibility
Recruits 6 Vulnerable population not selected (isVulnerablePopulationSelected:false).
- Vulnerable Population
- Vulnerable population not selected (isVulnerablePopulationSelected:false)
Recruitment
- Planned Sample Size
- 6
- Recruitment Window Months
- 19
Geography
- Total Number Of Sites
- 1
- Total Number Of Participants
- 6
Netherlands
- Earliest CTIS Part Ii Submission Date
- 05-02-2024
- Latest Decision Or Authorization Date
- 09-02-2024
- Processing Time Days
- 4
- Number Of Sites
- 1
- Number Of Participants
- 6
Sites
- Site Name
- Amsterdam UMC
- Department Name
- Internal Medicine
- Contact Person Name
- G.J. De Bree
- Contact Person Email
- g.j.debree@amsterdamumc.nl
- Number Of Participants
- 6
Sponsor
Primary sponsor
- Full Name
- International AIDS Vaccine Initiative Inc.
- Organisation Type
- Laboratory/Research/Testing facility
- Country Of Registered Address
- United States
Related trials
Other published trials that may interest you.
- Conditioned medium from a co-culture of M2-macrophages and fat-derived mesenchymal cells for Acute respiratory distress syndrome (ARDS) | SARS-CoV-2 infection | Influenza A infection | Influenza B infection | Respiratory syncytial virus (RSV) infection
- ACICLOVIR for Recurrent herpes labialis | Herpes simplex labialis
- AMIKACIN SULFATE for Sepsis | Neutropenia
- LENACAPAVIR, ISLATRAVIR for HIV-1 infection
- piperacillin sodium, tazobactam sodium for Extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae severe infection